Skip to main content
Decorative image of the Sepsis Learning Lounge

Nailing The Culprit Quickly: Syndromic Testing For Bloodstream Infection And Sepsis

SUMMARY

Part 1: Because Time Matters: The Role of Syndromic Testing in Optimising the Management of Bloodstream Infections.

Part 2: Implementing Syndromic Testing Into Routine Practice: Upholding the Principles of Antimicrobial Stewardship.

In this two-part medical education activity, participants will learn to:

  • Explain the rationale for syndromic testing in patients with bloodstream infections or sepsis
  • Summarize how syndromic testing supports the principles of antimicrobial stewardship
  • Apply the principles of diagnostic and laboratory stewardship to ensure appropriate use of syndromic testing, improve patient care, and reduce impact on healthcare services

This activity is supported by an educational grant from bioMérieux.

FEATURED EXPERT    

Timothy Miles Rawson, MBBS, BSc (Hons), PGdip Med Ed, DTM&H, MRCP (UK), PhD - Imperial College London; Imperial College Healthcare NHS Trust, London, UK

GET STARTED

Watch or listen to Parts 1 and 2 of this CME activity here, available in 5 languages including English, French, German, Italian, and Spanish.

Take me there now

Estimated reading time: 11 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

Sepsis

When time is critical, you need accurate information, and you need it fast. bioMérieux is your partner along the sepsis management pathway, offering the most comprehensive solution for sepsis diagnostics to optimize antibiotic therapy for better patient care.

Learn More

BIOFIRE® Blood Culture Identification 2 Panel

The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.

Learn More

PUBLISHED BY

PeerVoice
December 9, 2021

SHARE THIS ARTICLE: